Brickell Biotech Valuation
| BBI Stock | USD 0.98 0.04 4.26% |
Brickell Biotech Enterprise Value is decreasing as compared to previous years. The preceding year's Enterprise Value was reported at 4.47 Million. The current Tangible Asset Value is estimated to increase to about 35.1 M, while Free Cash Flow is projected to decrease to (33.4 M). Brickell Biotech shows a prevailing Real Value of $0.74 per share. The current price of the firm is $0.98. Today, the firm appears to be overvalued. Our model approximates the value of Brickell Biotech from analyzing the firm fundamentals such as Shares Outstanding of 2.87 M, operating margin of (6.58) %, and Return On Equity of -1.57 as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and trading away overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Beta 0.0796 | Enterprise Value -8.4 M | Net Debt -26.8 M | Accounts Payable 1.6 M | Other Operating Expenses 40.6 M |
Brickell Biotech Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Brickell Biotech's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today
Please note that Brickell Biotech's price fluctuation is out of control at this time. Calculation of the real value of Brickell Biotech is based on 3 months time horizon. Increasing Brickell Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Brickell Biotech is useful when determining the fair value of the Brickell stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Brickell Biotech. Since Brickell Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brickell Stock. However, Brickell Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Estimating the potential upside or downside of Brickell Biotech helps investors to forecast how Brickell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brickell Biotech more accurately as focusing exclusively on Brickell Biotech's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Brickell Biotech's intrinsic value based on its ongoing forecasts of Brickell Biotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Brickell Biotech's closest peers. When choosing an evaluation method for Brickell Biotech, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Brickell Biotech Investments |
|
Brickell Valuation Drivers Correlation
Many accounts on the financial statements of Brickell Biotech are highly interrelated and sometimes correlated. Consequently, when conducting Brickell's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Brickell
Click cells to compare fundamentals
Brickell Valuation Trend
Knowing Brickell Biotech's actual value is paramount for traders to make sound investment determinations. Brickell Biotech's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Brickell Biotech's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Brickell Biotech's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Brickell Market Cap
Brickell Biotech is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 466.45 Billion. Brickell Biotech adds roughly 6.75 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Brickell Biotech Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Brickell Biotech's current stock value. Our valuation model uses many indicators to compare Brickell Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brickell Biotech competition to find correlations between indicators driving Brickell Biotech's intrinsic value. More Info.Brickell Biotech is number one stock in net asset category among related companies. It is number one stock in price to book category among related companies . The ratio of Net Asset to Price to Book for Brickell Biotech is about 72,498,170 . The current Price to Book Value is estimated to increase to 1.15. Comparative valuation analysis is a catch-all model that can be used if you cannot value Brickell Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brickell Biotech's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brickell Biotech's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brickell Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brickell Biotech and how it compares across the competition.
About Brickell Biotech Valuation
The stock valuation mechanism determines the current worth of Brickell Biotech on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Brickell Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Brickell Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Brickell Biotech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Brickell Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brickell Biotech. We calculate exposure to Brickell Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Brickell Biotech's related companies.| Last Reported | Projected for 2023 | ||
| Gross Profit | 363.6 K | 373.2 K | |
| Profit Margin | (107.85) | (116.36) |
8 Steps to conduct Brickell Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brickell Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brickell Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Brickell Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Brickell Biotech's revenue streams: Identify Brickell Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Brickell Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Brickell Biotech's growth potential: Evaluate Brickell Biotech's management, business model, and growth potential.
- Determine Brickell Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brickell Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Brickell Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Brickell Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 M |
Brickell Biotech Current Valuation Indicators
Valuation refers to the process of determining the present value of Brickell Biotech and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Brickell we look at many different elements of the entity such as Brickell's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Brickell Biotech's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Brickell Biotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Brickell Biotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Brickell Biotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Brickell Biotech's worth.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Brickell Stock analysis
When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEO Directory Screen CEOs from public companies around the world |
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.42) | Revenue Per Share 1.94 | Quarterly Revenue Growth 27.576 | Return On Assets (0.80) | Return On Equity (1.57) |
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.